Implementation of Tofersen Expanded Access Program (EAP) in the US, The Cumulative Experience of Six Academic Centers.

被引：0
|
作者：
Ajroud-Driss, Senda [1 ]
Babu, Suma [2 ]
Harms, Matthew [3 ]
Shneider, Neil [3 ]
Quinn, Colin [4 ]
Arcila-Londono, Ximena [5 ]
Bucelli, Robert [6 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL USA
[2] Harvard Med Sch, Dept Neurol, Boston, MA USA
[3] Columbia Univ, Dept Neurol, Vagelos Coll Physicians & Surg, New York, NY USA
[4] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA USA
[5] Henry Ford Hlth Detroit, Med Harry J Hoenselaar ALS Clin, Detroit, MI USA
[6] Washington Univ, Dept Neurol, Sch Med, St Louis, MO USA
来源：
MUSCLE & NERVE | 2023年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
126
引用
收藏
页码：S59 / S60
页数：2
相关论文
共 26 条
  • [1] A single-institution experience with the pembrolizumab (PEM) Expanded Access Program (EAP)
    Perdon, Karen Mae
    Kim, Dae Won
    Balmes, Gener C.
    VanAnh Trinh
    McIntyre, Susan E.
    Diab, Adi
    Amaria, Rodabe Navroze
    Patel, Sapna Pradyuman
    Hwu, Patrick
    James, Marihella
    Philip, Ann
    Vardeleon, Anna
    Cain, Suzanne
    Hwu, Wen-Jen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Ipilimumab retreatment following induction therapy: The expanded access program (EAP) experience
    Margolin, Kim Allyson
    Hamid, Omid
    Weber, Jeffrey S.
    Pavlick, Anna C.
    Hodi, F. Stephen
    Amin, Asim
    Bennett, Kelly
    Michener, Tracy
    Minor, David R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] NUSINERSEN FOR SMA1: THE ITALIAN EXPANDED ACCESS PROGRAM (EAP) EXPERIENCE
    Albamonte, E.
    Pane, M.
    Messina, S.
    D'Amico
    Bertini, E.
    Bruno, C.
    Vita, G.
    Casiraghi, J.
    Binetti, L.
    Mercuri, E.
    Sansone, V. A.
    MUSCLE & NERVE, 2017, 56 : S2 - S3
  • [4] The use of nusinersen in the "real world": the UK and Ireland experience with the expanded access program (EAP)
    Scoto, M.
    Manzue, A.
    Main, M.
    Munot, P.
    Tillmann, R.
    Bettolo, C. Marini
    Mayhew, A.
    Muni-Lofra, R.
    White, K.
    Baxter, P.
    Tirupathi, S.
    Douglas, I.
    Douglas, M.
    Macauley, S.
    Childs, A-M
    O'Rourke, D.
    Hartley, L.
    Hughes, I.
    McCullagh, G.
    Spinty, S.
    Madhu, R.
    Gregson, S.
    Gowda, V.
    Wraige, E.
    Horrocks, I.
    Brunklaus, A.
    Di Marco, M.
    Dunne, J.
    Brown, S.
    Mochrie, R.
    Illingworth, M.
    Krishnakumar, D.
    Kirkpatrick, M.
    Ramdas, S.
    Vijayakumar, K.
    Selby, V.
    Kulshrestha, R.
    Willis, T.
    Straub, V.
    Muntoni, F.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S25 - S25
  • [5] Radium-223 dichloride (Ra-223) in US expanded access program (EAP).
    Vogelzang, Nicholas J.
    Fernandez, Daniel Celestino
    Morris, Michael J.
    Iagaru, Andrei
    Brown, Alan
    Almeida, Fabio
    Sweeney, Christopher
    Smith, Matthew Raymond
    Dicker, Adam
    Wong, Yu-Ning
    Shore, Neal D.
    Bangerter, Keith
    Petrenciuc, Oana
    Sartor, A. Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [6] Teprotumumab for the Treatment of Thyroid Eye Disease: Clinical Experience from Expanded Access Program (EAP)
    Wang, Yao
    Mester, Tunde
    Ugradar, Shoaib
    Douglas, Raymond
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [7] EXPERIENCE FROM THE US VOXELOTOR EXPANDED ACCESS PROGRAM FOR CHILDREN WITH SICKLE CELL DISEASE
    Brown, Robert Clark
    Owusu-Ansah, Amma
    Yang, Elizabeth
    Mian, Amir
    Rivlin, Kenneth
    Johnson, Clarissa
    Pendleton, Andrew
    Singh, Sharon
    Shah, Sanjay
    Narang, Shalu
    Miller, Robin
    Darbari, Deepika
    Anderson, Alan
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [8] Avelumab treatment of Australian patients with metastatic Merkel cell carcinoma (mMCC): Experience from an expanded access program (EAP)
    van Hagen, Tom
    Sandhu, Shahneen
    Kasturi, Vijay
    Steer, Christopher
    Khoo, Chloe
    Nordman, Ina
    Hennessy, Meliessa
    Hildemann, Steven
    Reed, Josh
    Hariharan, Subramanian
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 173 - 174
  • [9] Alectinib Following Prior ALK Tyrosine Kinase Inhibitor (TKI) Therapy: Results from the US Expanded Access Program (EAP)
    Patel, J. D.
    Gadgeel, S. M.
    Ou, S. I.
    Le Maitre, A.
    Schulz, M.
    Liu, S.
    Zeaiter, A.
    Balas, B.
    Gupta, R.
    Shaw, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1573 - S1573
  • [10] TO BUILD AN ACADEMIC GERIATRIC PROGRAM OF DISTINCTION - LESSONS FROM EXPERIENCE AT 3 US AND 2 BRITISH ACADEMIC HEALTH CENTERS
    HAZZARD, WR
    AMERICAN JOURNAL OF MEDICINE, 1994, 97 : 6 - 7
123